1. Home
  2. ANGH vs CTSO Comparison

ANGH vs CTSO Comparison

Compare ANGH & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anghami Inc.

ANGH

Anghami Inc.

HOLD

Current Price

$3.93

Market Cap

36.3M

ML Signal

HOLD

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.61

Market Cap

38.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANGH
CTSO
Founded
2012
1997
Country
United Arab Emirates
United States
Employees
186
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.3M
38.2M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
ANGH
CTSO
Price
$3.93
$0.61
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.38
AVG Volume (30 Days)
3.3K
98.7K
Earning Date
04-30-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.79
EPS
N/A
N/A
Revenue
N/A
$22,503,908.00
Revenue This Year
N/A
$10.34
Revenue Next Year
N/A
$22.41
P/E Ratio
N/A
N/A
Revenue Growth
N/A
48.53
52 Week Low
$0.25
$0.50
52 Week High
$7.05
$1.39

Technical Indicators

Market Signals
Indicator
ANGH
CTSO
Relative Strength Index (RSI) 60.20 46.17
Support Level $2.83 $0.50
Resistance Level $5.27 $0.74
Average True Range (ATR) 0.24 0.05
MACD 0.01 0.00
Stochastic Oscillator 82.69 62.45

Price Performance

Historical Comparison
ANGH
CTSO

About ANGH Anghami Inc.

Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. It generates the majority of its revenue from subscriptions.

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Share on Social Networks: